Researchers seek patients with primary progressive MS for clinical trial

October 10, 2022
Researchers at various sites across the globe are conducting the FENtrepid Study to see if an investigational study drug can be a safe and effective treatment option for primary progressive multiple sclerosis.

The FENtrepid Study is assessing how safe and effective the investigational study drug is in treating PPMS, compared to an approved comparison drug that is already being used to treat patients with PPMS.

Participants must be:
  • aged between 18 and 65, 
  • diagnosis of PPMS,
  • able to complete MRI, and
  • willing to complete onsite clinic visit

If you are interested in learning more about the study and see if you may qualify to participate, please complete this online pre-screener. If your answers indicate you may be eligible, you will be given the opportunity to contact a clinic site near you to learn more about the study.

For more details on the FENtrepid study, please visit the fenstudies.com website or call 888- 662-6728.

MS Focus Lending Library


Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more